Olmesartan Medoxomil Pricing showcased a stable trend in the North American region, followed by market disruptions. Supply disruptions from the APAC region amid high transportation costs resulted in a shortage of inventories, impacting the price dynamics of Olmesartan Medoxomil in the USA. Hampered production activities due to the COVID-19 lockdown curbs in China caused disruptions in the supply chain between USA and China. Due to the shortage of containers, domestic downstream customers had trouble getting their hands on supplies. Stability in the downstream demand from the pharmaceutical industry and high inflation pressure on the enterprises kept costs steady in the second quarter of 2022. Towards the end of Q2 of 2022, Olmesartan Medoxomil prices were assessed at USD 739506/MT for CFR New York in June 2022.